Skip to Main Content

Author Details

Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
1994
191
55
PMIDPaper TitleJournal TitlePublished Year
38050344Regulation of the innate immune response and gut microbiome by p53.Cancer Sci2024
38083992Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma.Cancer Sci2024
38013050Immuno-genomic analysis reveals eosinophilic feature and favorable prognosis of female non-smoking esophageal squamous cell carcinomas.Cancer Lett2024
32341528Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers.Nat Genet2023
37945903Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.Nat Genet2023
37612283Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.Nat Commun2023
37686510Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment.Cancers (Basel)2023
36988593<i>Helicobacter pylori</i>, Homologous-Recombination Genes, and Gastric Cancer.N Engl J Med2023
37315111Increased PDGFRB and NF-κB signaling caused by highly prevalent somatic mutations in intracranial aneurysms.Sci Transl Med2023
37182269Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma.EBioMedicine2023
36697832Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.Nature2023
36870059Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma.Cell Rep2023
36905328Variant spectrum of von Hippel-Lindau disease and its genomic heterogeneity in Japan.Hum Mol Genet2023
36451303Immunotherapies targeting neoantigens are effective in PD-1 blockade-resistant tumors.Int J Cancer2023
36243179Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer.J Hepatol2023
35981075Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis.Hum Mol Genet2023
32047324Publisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers.Nat Genet2023
33309985Population-based Screening for Hereditary Colorectal Cancer Variants in Japan.Clin Gastroenterol Hepatol2022
35764097Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls.Hum Mol Genet2022
35420638Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.JAMA Oncol2022
36480778Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care.JCO Precis Oncol2022
36676020COOBoostR: An Extreme Gradient Boosting-Based Tool for Robust Tissue or Cell-of-Origin Prediction of Tumors.Life (Basel)2022
36481652Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations.Nat Commun2022
35874919Single-cell transcriptomes underscore genetically distinct tumor characteristics and microenvironment for hereditary kidney cancers.iScience2022
36309506Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets.Nat Commun2022
36065483Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk.Cancer Sci2022
35986085Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer.Br J Cancer2022
35926060Comprehensive analysis of full-length transcripts reveals novel splicing abnormalities and oncogenic transcripts in liver cancer.PLoS Genet2022
36093724Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese.Jpn J Clin Oncol2022
36054900The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.Int J Cancer2022
35944530Immuno-genomic profiling of biopsy specimens predicts neoadjuvant chemotherapy response in esophageal squamous cell carcinoma.Cell Rep Med2022
35118230Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy.JNCI Cancer Spectr2022
34962019Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1.Cancer Sci2022
34411400Bile acid dysmetabolism in the gut-microbiota-liver axis under hepatitis C virus infection.Liver Int2022
33473200Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
33910608Whole-genome sequencing with long reads reveals complex structure and origin of structural variation in human genetic variations and somatic mutations in cancer.Genome Med2021
33658639Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profiling.Br J Cancer2021
33578820Molecular Classification and Tumor Microenvironment Characterization of Gallbladder Cancer by Comprehensive Genomic and Transcriptomic Analysis.Cancers (Basel)2021
35072136GA4GH: International policies and standards for data sharing across genomic research and healthcare.Cell Genom2021
35008270Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy.Cancers (Basel)2021
34824211Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture.Nat Commun2021
34538872Genetic and epigenetic basis of hepatoblastoma diversity.Nat Commun2021
34771674Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1.Cancers (Basel)2021
34344966Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories.Sci Rep2021
34316332Actionability evaluation of biliary tract cancer by genome transcriptome analysis and Asian cancer knowledgebase.Oncotarget2021
33978893Characterization of intermediate-sized insertions using whole-genome sequencing data and analysis of their functional impact on gene expression.Hum Genet2021
33398198Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
31214711Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls.J Natl Cancer Inst2020
35050733Prevalence and Spectrum of Pathogenic Germline Variants in Japanese Patients With Early-Onset Colorectal, Breast, and Prostate Cancer.JCO Precis Oncol2020
32083210Somatic mutation landscape reveals differential variability of cell-of-origin for primary liver cancer.Heliyon2020
  • 1 - 50 of 191

Recommended Authors

Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 3
Qi Zhao
University of Science and Technology Liaoning
Career Start Year 2009
Number of shared co-authors 1
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 6
Daizhan Zhou
The Fourth Affiliated Hospital, Zhejiang University School of Medicine
Career Start Year 2008
Number of shared co-authors 1
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 26
Katia Nones
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 22
Sadakatsu Ikeda
Tokyo Medical and Dental University Hospital
Career Start Year 2006
Number of shared co-authors 2
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 10
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 5
Bin Feng
The First Affiliated Hospital of Jinan University
Career Start Year 2004
Number of shared co-authors 5
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 3
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 22
Raphael B Parmigiani
Sirio-Libanes Hospital
Career Start Year 2002
Number of shared co-authors 0
Howard H Yang
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 4
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 5
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 19
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 15
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 1
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 41
David Cogdell
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 3
Liang Wang
H. Lee Moffitt Cancer Center
Career Start Year 1996
Number of shared co-authors 15
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 3
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 14
Phillip Buckhaults
University of South Carolina
Career Start Year 1993
Number of shared co-authors 0
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 33
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 9
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 25
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 55

Collaborators

Yusuke Nakamura
Japanese Foundation for Cancer Research
Co-authored papers 49
Michiaki Kubo
Co-authored papers 33
Akihiro Fujimoto
Graduate School of Medicine, The University of Tokyo
Co-authored papers 32
Satoru Miyano
Tokyo Medical and Dental University
Co-authored papers 27
Tatsuhiko Tsunoda
The University of Tokyo
Co-authored papers 26
Hiroko Tanaka
Tokyo Medical and Dental University
Co-authored papers 16
Seiya Imoto
Human Genome Center, The Institute of Medical Science, The University of Tokyo
Co-authored papers 15
Yoichiro Kamatani
Co-authored papers 14
Atsushi Takahashi
Co-authored papers 14
Albert de la Chapelle
The Ohio State University Comprehensive Cancer Center
Co-authored papers 13
Christopher A Haiman
University of Southern California
Co-authored papers 11
Tatsuhiro Shibata
Kurume University School of Medicine
Co-authored papers 9
Loic Le Marchand
Co-authored papers 8
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 7
Douglas F Easton
University of Cambridge
Co-authored papers 7
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers 7
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers 6
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 6
Elio Riboli
Co-authored papers 5
Rick A Kittles
Morehouse School of Medicine
Co-authored papers 5
William J Blot
Vanderbilt University Medical Center
Co-authored papers 5
Stephanie J Weinstein
Co-authored papers 5
John D Carpten
Co-authored papers 5
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Sue A Ingles
Co-authored papers 5
Han Liang
MD Anderson Cancer Center
Co-authored papers 5
Brian E Henderson
University of Southern California
Co-authored papers 5
Demetrius Albanes
Co-authored papers 5
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 5
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers 5
Release 1.2